Bosh sahifaAVH • ASX
add
AVITA Medical Inc
Yopilish kursi
1,81 $
Kunlik diapazon
1,86 $ - 1,90 $
Yillik diapazon
1,75 $ - 4,52 $
Bozor kapitalizatsiyasi
244,07 mln AUD
Oʻrtacha hajm
346,14 ming
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 18,51 mln | 66,73% |
Joriy xarajat | 27,51 mln | 2,65% |
Sof foyda | -13,86 mln | 25,72% |
Sof foyda marjasi | -74,86 | 55,45% |
Har bir ulushga tushum | -0,83 | 25,24% |
EBITDA | -11,31 mln | 33,51% |
Amaldagi soliq stavkasi | -0,06% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 25,82 mln | -62,13% |
Jami aktivlari | 69,56 mln | -28,57% |
Jami passivlari | 74,13 mln | 14,37% |
Umumiy kapital | -4,57 mln | — |
Tarqatilgan aksiyalar | 26,43 mln | — |
Narxi/balansdagi bahosi | -10,62 | — |
Aktivlardan daromad | -39,62% | — |
Kapitaldan daromad | -65,72% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -13,86 mln | 25,72% |
Operatsiyalardan naqd pul | -10,31 mln | 50,59% |
Sarmoyadan naqd pul | 10,77 mln | -28,54% |
Moliyadan naqd pul | 363,00 ming | -42,47% |
Naqd pulning sof oʻzgarishi | 820,00 ming | 115,87% |
Boʻsh pul | -2,52 mln | 82,32% |
Haqida
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Tashkil etilgan
1999
Sayt
Xodimlar soni
260
